Cartwright Jennifer A, Lucas Christopher D, Rossi Adriano G
Queen's Medical Research Institute, University of Edinburgh Centre for Inflammation Research, Edinburgh BioQuarter, Edinburgh, United Kingdom.
MRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh BioQuarter, Edinburgh, United Kingdom.
Front Pharmacol. 2019 Feb 19;10:55. doi: 10.3389/fphar.2019.00055. eCollection 2019.
Inflammation is a necessary dynamic tissue response to injury or infection and it's resolution is essential to return tissue homeostasis and function. Defective or dysregulated inflammation resolution contributes significantly to the pathogenesis of many, often common and challenging to treat human conditions. The transition of inflammation to resolution is an active process, involving the clearance of inflammatory cells (granulocytes), a change of mediators and their receptors, and prevention of further inflammatory cell infiltration. This review focuses on the use of cyclin dependent kinase inhibitor drugs to pharmacologically target this inflammatory resolution switch, specifically through inducing granulocyte apoptosis and phagocytic clearance of apoptotic cells (efferocytosis). The key processes and pathways required for granulocyte apoptosis, recruitment of phagocytes and mechanisms of engulfment are discussed along with the cumulating evidence for cyclin dependent kinase inhibitor drugs as pro-resolution therapeutics.
炎症是机体对损伤或感染的一种必要的动态组织反应,炎症的消退对于恢复组织稳态和功能至关重要。炎症消退存在缺陷或失调在许多人类疾病(往往常见且治疗具有挑战性)的发病机制中起重要作用。炎症向消退的转变是一个活跃的过程,涉及炎症细胞(粒细胞)的清除、介质及其受体的变化以及防止进一步的炎症细胞浸润。本综述重点关注使用细胞周期蛋白依赖性激酶抑制剂药物从药理学角度靶向这种炎症消退转换,特别是通过诱导粒细胞凋亡和凋亡细胞的吞噬清除(胞葬作用)。本文讨论了粒细胞凋亡、吞噬细胞募集以及吞噬机制所需的关键过程和途径,以及细胞周期蛋白依赖性激酶抑制剂药物作为促消退治疗药物的累积证据。